Skip to main content
Caplight Logo









iSTAR Medical

iSTAR Medical

Private
WavreHealthcare & Life Scienceshttps://www.istar-medical.com/

Last Round

Corporate Funding

Jul 20, 2022

Total Funding Raised

$148.29M

Company Overview

iSTAR Medical is a medtech company that develops and commercializes minimally-invasive implants designed for bio-integration to treat glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

MIGS deviceglaucoma implantminimally invasive glaucoma surgeryMIGSglaucoma surgeryophthalmologymedtechopen-angle glaucomaintraocular pressure reductionmedical deviceophthalmic implantsupraciliary implantbio-integrating implantanti-fibrotic implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iSTAR Medical Comparables

Compare iSTAR Medical with similar companies based on industry and business-model similarity.

iSTAR Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sanoculis
88%
Ciliatech
86%
Iantrek
84%

iSTAR Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJul 20, 2022
DebtNov 26, 2021
Series CSep 5, 2019
Series BApr 12, 2016
Series ANov 21, 2013
Grant
Sep 14, 2012

Key People

Founding team and executive leadership

Michel Vanbrabant

CEO

Executive Team

Xavier Dillen

Chief Financial Officer

Executive Team

iSTAR Medical Investors

Notable investors and investment history

iSTAR Medical investors
InvestorRounds
Federal Holding and Investment CompanySeries C, Series B
EQT Life SciencesSeries C
Capricorn PartnersSeries C, Series B
GimvSeries C
Capricorn Health-tech FundSeries A
European Investment Bank GroupDebt
Namur InvestSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Monthly visitors increased 82% MoM.

  • May 3, 2025

    Monthly visitors increased 149% MoM, reaching 2.2K.

iSTAR Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iSTAR Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iSTAR Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWavre
Employee Range37
Year Founded2010
Last FundingJul 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?